Coronavirus India | Cipla to soon launch COVID-19 drug Ciplenza at Rs 68 per tablet - Moneycontrol 25-Jul-2020

on

Coronavirus India | Cipla to soon launch COVID-19 drug Ciplenza at Rs 68 per tablet - Moneycontrol


Favipiravir, which is known to quicken the pace of clinical recovery of COVID-19 patients, is an oral anti-viral drug under the brand name Ciplenza

More...